Results 91 to 100 of about 15,884 (195)
Virology JournalBackground No study has comparing hepatitis B virus (HBV) relapse rates among patients with both cancer and hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) who completed anti-viral prophylaxis for chemotherapy and then stopped taking ...
Hsin-Wei Fang +6 more
doaj +1 more source
Management of Antiviral Resistance in Chronic Hepatitis B
Gut and Liver, 2017 The primary goal of therapy for chronic hepatitis B (CHB) is to prevent liver disease progression. Hepatitis B surface antigen (HBsAg) seroclearance or seroconversion is regarded as an optimal endpoint to discontinue treatment.
Young-Suk Lim
doaj +1 more source
Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome [PDF]
, 2015 Background: Selection of amino acid substitutions associated with resistance to nucleos(t)ide-analog (NA) therapy in the hepatitis B virus (HBV) reverse transcriptase (RT) and their combination in a single viral genome complicates treatment of chronic ...
Buti, María +2 more
core +2 more sources
Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials [PDF]
, 2012 Background The studies on the effectiveness of Chinese herbal medicines (CHM) in treating liver fibrosis (LF) were not consistent. This study aims to systematically review the effectiveness of CHM on treating LF patients.
Fan Cheung +5 more
core +2 more sources
Total synthesis of entecavir [PDF]
, 2013 Entecavir (BMS-200475) was synthesized from 4-trimethylsilyl-3-butyn-2-one and acrolein. The key features of its preparation are: (i) a stereoselective boron-aldol reaction to afford the acyclic carbon skeleton of the methylenecylopentane moiety; (ii ...
Ariza Piquer, Xavier +8 more
core +2 more sources
Severe Acute Hepatitis B Treated with Entecavir
Mediterranean Journal of Hematology and Infectious Diseases, 2011 Hepatitis B virus (HBV) infection constitutes a serious global health problem. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B.
Giuseppe Vittorio Luigi De Socio +3 more
doaj +1 more source
Evolution of hepatitis B management in kidney transplantation [PDF]
, 2014 published_or_final_versio
Chan, DTM, Yap, YHD
core +1 more source
Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management [PDF]
, 2018 Chronic hepatitis B (CHB) is a major global health problem affecting an estimated 350 million people with more than 786000 individuals dying annually due to complications, such as cirrhosis, liver failure and hepatocellular carcinoma (HCC).
Chauhan, Ranjit +7 more
core +2 more sources
Antivirais incorporados no Brasil para hepatite B cronica: analise de custo-efetividade
Revista de Saúde Pública, 2013 OBJETIVO Avaliar o custo-efetividade de diferentes tratamentos medicamentosos para hepatite B crônica entre pacientes adultos. MÉTODOS Utilizando modelo de Markov, construiu-se coorte hipotética de 40 anos para pacientes HBeAg-positivo ou HBeAg ...
Gustavo Laine Araujo de Oliveira +6 more
doaj +1 more source
ToxicsEntecavir (ETV) is an antiviral used to treat chronic infection caused by the hepatitis B virus, which affects approximately 250 million people worldwide.
Cléssius Ribeiro de Souza +7 more
doaj +1 more source